SCHEMBL22866555

SCHEMBL22866555

C=C(OCC)c1ncc(F)cc1Br

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AGBL2 Q5U5Z8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29560210 1.00 AGBL2 (0.33) AGBL2
SCHEMBL31447876 0.81 ALDH1A1 (0.37) AGBL2
SCHEMBL31310325 0.76 MAPT (0.45) —
SCHEMBL23293554 0.73 DGAT1 (0.32) AGBL2
SCHEMBL29183346 0.73 OPRK1 (0.37) AGBL2
SCHEMBL30741506 0.73 OPRK1 (0.37) AGBL2
SCHEMBL31382642 0.72 CHEK2 (0.39) AGBL2
SCHEMBL28495539 0.72 S1PR1 (0.39) —
SCHEMBL30741539 0.71 AGBL2 (0.39) AGBL2
SCHEMBL23649897 0.70 DGAT1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021003157-A1 EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS EFFECTOR THERAPEUTICS, INC. (US) 2021-01-07 — — WO disclosed
Send feedback